HotSheets by Year

 

Hot SHEET 2018

Made possible by charitable contributions from

Pfizer
Astellas
BAYER
CyberKnife
 

 - Thank You!

 

Our monthly newsletter, the Hot SHEET, highlights the latest in treatment strategies as well as emerging treatments. The Hot SHEET is distributed free at chapter support group meetings, and is available in PDF on the Us TOO web site.

Hot SHEET Personal Subscriptions Now Available

If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office. Download and print a subscription order form or order online.



  • Yearly Biopsy Not Needed for Prostate Cancer Surveillance
  • When PSA Is 4-10 ng/mL, phi Test Helps with Biopsy Decision
  • Cancer Survivors & PTSD
  • Phase 1 Trial of ProscaVax Vaccine Stopped PCa Progression
  • Amiloride for Managing Abiraterone-Induced Mineralocorticoid Excess
  • Doc Moyad’s No Bogus Science: "Low-Calorie Diet & Weight Loss"
  • Index of Medical Articles Published in the 2017 Us TOO Hot SHEET
  • Doctor Chodak’s Bottom Line
  • Existing Parasite Drug May Fight 8 Prostate and Colon Cancers
  • Enzalutamide Safe in Seizure-Prone Prostate Cancer Patients
  • Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications
  • Metastasis-Directed Treatment Improves Progression-Free Survival
  • New Prostate Cancer Imaging Tracer
  • Doc Moyad’s No Bogus Science: “Exercise and the Risk of Dementia?”
  • Shorter but Higher Dose of RT Cuts Risk of Prostate Cancer Recurrence
  • Circulating Tumor Cell Count Predicts Overall Survival in Prostate Cancer
  • NCCN: Favorable vs. Unfavorable Intermediate-Risk Prostate Cancer
  • Safety Concerns with Trial of Xofigo/Zytiga Combination
  • Contemporary Incidence and Outcome of Lymph Node Metastases
  • Smaller Difference in PCa Death Risk Found Between RP & RT
  • Doctor Chodak’s Bottom Line

 

CLICK HERE and opt-in to receive free educational emails from Us TOO.